Ozempic & Weight Loss: Ro’s Next Growth Phase 🚀
Ro CEO Zach Reitano on GLP-1s, Serena Williams, and the Future of Healthcare The landscape of weight management and metabolic health is undergoing a rapid transformation, driven by the surging popularity of GLP-1 receptor agonists like Ozempic, Wegovy, and Zepbound. Ro, a leading telehealth company, is at the forefront of this revolution, navigating both the … Read more